Skip to Main Content

Author Details

Yelena Z Ginzburg
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
2007
54
24
PMIDPaper TitleJournal TitlePublished Year
36315910Dietary iron restriction protects against vaso-occlusion and organ damage in murine sickle cell disease.Blood2023
37717987Hepcidin and its multiple partners: Complex regulation of iron metabolism in health and disease.Vitam Horm2023
37528578Erythropoietin-secreting metanephric adenoma presenting as erythrocytosis.Am J Hematol2023
37578340Normal and dysregulated crosstalk between iron metabolism and erythropoiesis.Elife2023
37199228Emerging roles of brain tanycytes in regulating blood-hypothalamus barrier plasticity and energy homeostasis.Ann N Y Acad Sci2023
37066218The hepatokine FGL1 regulates hepcidin and iron metabolism during the recovery from hemorrhage-induced anemia in mice.bioRxiv2023
36656634Bone circuitry and interorgan skeletal crosstalk.Elife2023
36872867Single-cell profiling of ineffective erythropoiesis in a mouse model of β-thalassaemia intermedia.Br J Haematol2023
36728649Hepcidin mimetics in polycythemia vera: resolving the irony of iron deficiency and erythrocytosis.Curr Opin Hematol2023
33237986Clinical insights into the origins of thrombosis in myeloproliferative neoplasms.Blood2021
33810899Tackling the unknowns in understanding and management of hospital acquired anemia.Blood Rev2021
34890402Tmprss6-ASO as a tool for the treatment of Polycythemia Vera mice.PLoS One2021
33941818Pleckstrin-2 is essential for erythropoiesis in β-thalassemic mice, reducing apoptosis and enhancing enucleation.Commun Biol2021
34002695The hepcidin regulator erythroferrone is a new member of the erythropoiesis-iron-bone circuitry.Elife2021
31418854GDF11 contributes to hepatic hepcidin (HAMP) inhibition through SMURF1-mediated BMP-SMAD signalling suppression.Br J Haematol2020
31968250Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.Cell Rep2020
31961822Donor glucose-6-phosphate dehydrogenase deficiency decreases blood quality for transfusion.J Clin Invest2020
31582543Minihepcidins improve ineffective erythropoiesis and splenomegaly in a new mouse model of adult β-thalassemia major.Haematologica2020
30783732Inhaled steroids associated with decreased macrophage markers in nonasthmatic individuals with sickle cell disease in a randomized trial.Ann Hematol2019
31808893New diagnostic tools for delineating iron status.Hematology Am Soc Hematol Educ Program2019
31434707Lobe specificity of iron binding to transferrin modulates murine erythropoiesis and iron homeostasis.Blood2019
30798811Hepcidin-ferroportin axis in health and disease.Vitam Horm2019
31002399Reexamination of the chromium-51-labeled posttransfusion red blood cell recovery method.Transfusion2019
29600572Adenine alleviates iron overload by cAMP/PKA mediated hepatic hepcidin in mice.J Cell Physiol2018
30076048Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease.EBioMedicine2018
30042411Dysregulated iron metabolism in polycythemia vera: etiology and consequences.Leukemia2018
30467188<i>Tfr2</i> suppression benefits β-thalassemic erythropoiesis.Blood2018
27941245Prolonged red cell storage before transfusion increases extravascular hemolysis.J Clin Invest2017
28328181Role of hepcidin-ferroportin axis in the pathophysiology, diagnosis, and treatment of anemia of chronic inflammation.Hemodial Int2017
28151426Decreasing TfR1 expression reverses anemia and hepcidin suppression in β-thalassemic mice.Blood2017
28784700Serum Iron Protects from Renal Postischemic Injury.J Am Soc Nephrol2017
28739636Immunoassay for human serum erythroferrone.Blood2017
26915437Evidence of relative iron deficiency in platelet- and plasma-pheresis donors correlates with donation frequency.J Clin Apher2016
26635037Increased hepcidin in transferrin-treated thalassemic mice correlates with increased liver BMP2 expression and decreased hepatocyte ERK activation.Haematologica2016
27154187Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera.Blood2016
24821751Iron dosing in kidney disease: inconsistency of evidence and clinical practice.Nephrol Dial Transplant2015
25307880Altered erythropoiesis and iron metabolism in carriers of thalassemia.Eur J Haematol2015
24658077An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.Nat Med2014
24923296Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome.Blood2014
23113726How do I provide leukapheresis products? Blood center experience and evidence for process improvement.Transfusion2013
23414144Why has Borrelia burgdorferi not been transmitted by blood transfusion?Transfusion2013
23287863Quantitative analysis of murine terminal erythroid differentiation in vivo: novel method to study normal and disordered erythropoiesis.Blood2013
22461476Decreased hepcidin expression in murine β-thalassemia is associated with suppression of Bmp/Smad signaling.Blood2012
22858567Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience.J Pediatr Hematol Oncol2012
21480335Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice.Hepatology2011
22021369Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron.Blood2011
21768301β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.Blood2011
20098432Transferrin therapy ameliorates disease in beta-thalassemic mice.Nat Med2010
21099112Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.J Clin Invest2010
20712768Iron metabolism and ineffective erythropoiesis in beta-thalassemia mouse models.Ann N Y Acad Sci2010
  • 1 - 50 of 54

Recommended Authors

Cancer & Blood Diseases Institute, Cincinnati Children's Hospital Medical Center
Career Start Year 2015
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 2013
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 1
University of Alabama at Birmingham Birmingham
Career Start Year 2009
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 2009
Number of shared co-authors 0
University of Washington School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Guangzhou University
Career Start Year 2007
Number of shared co-authors 0
Boston Children's Hospital, Harvard Medical School
Career Start Year 2006
Number of shared co-authors 0
MRC Weatherall Institute of Molecular Medicine, University of Oxford
Career Start Year 2005
Number of shared co-authors 0
John R. Oishei Children's Hospital of Buffalo
Career Start Year 2002
Number of shared co-authors 3
Center for Sickle Cell Disease, Howard University College of Medicine
Career Start Year 2000
Number of shared co-authors 0
and Blood Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 0
Pittsburgh Heart Lung and Blood Vascular Medicine Institute, University of Pittsburgh
Career Start Year 1998
Number of shared co-authors 4
Novartis Institutes for BioMedical Research
Career Start Year 1997
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1997
Number of shared co-authors 0
Smilow Cancer Center, Yale University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Departments of Hematology at Children's National Hospital
Career Start Year 1996
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1996
Number of shared co-authors 4
Cincinnati Children's Hospital Medical Center
Career Start Year 1995
Number of shared co-authors 0
Vanderbilt University Medical Center
Career Start Year 1995
Number of shared co-authors 0
Hospital
Career Start Year 1992
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1990
Number of shared co-authors 3
Western University
Career Start Year 1986
Number of shared co-authors 1
La Jolla Pharmaceutical Company
Career Start Year 1983
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1978
Number of shared co-authors 1
University of Washington
Career Start Year 1973
Number of shared co-authors 1
National Heart Lung and Blood Institute Division of Intramural Research
Career Start Year 1972
Number of shared co-authors 1
The Johns Hopkins University School of Medicine
Career Start Year 1968
Number of shared co-authors 1
The University of Queensland
Career Start Year 1962
Number of shared co-authors 1
Sidney Kimmel Cancer Center, Johns Hopkins University
Career Start Year 1958
Number of shared co-authors 1

Collaborators

Marcus Center for Cellular Cures, Duke University
Co-authored papers 6
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 4
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 4
Clinical Services
Co-authored papers 4
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 4
University of Virginia
Co-authored papers 3
Columbia University Irving Medical Center
Co-authored papers 3
Columbia University Medical Center Kreitchman PET Center
Co-authored papers 3
Department of Radiology Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Gui de Chauliac Hospital, Montpellier University Medical Center
Co-authored papers 3
Columbia University Irving Medical Center
Co-authored papers 3
Columbia University Irving Medical Center, New York-Presbyterian Hospital
Co-authored papers 2
Thyroid Research Unit, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Columbia University Vagelos College of Physicians and Surgeons
Co-authored papers 2
University of Colorado Anschutz Medical Campus
Co-authored papers 2
NewYork-Presbyterian/Columbia University Irving Medical Center
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 2
Albert Einstein College of Medicine
Co-authored papers 1
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
Lille University Hospital, INSERM UMR-S7, CNRS UMR9020, Lille University.
Co-authored papers 1
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 1
University of Colorado Anschutz Medical Campus
Co-authored papers 1
Center for Transfusion and Cellular Therapy, Emory University School of Medicine
Co-authored papers 1
Co-authored papers 1
College of Forestry, Shenyang Agricultural University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1